Molecular Partners Ag (MOLN) Goodwill & Intangibles (2020 - 2026)
Molecular Partners Ag (MOLN) posted quarterly Goodwill & Intangibles of $1.28 for Q1 2026, down 95.22% year-on-year from $26.69 in Q1 2025, and down 48.97% on a QoQ basis from $2.5 in Q4 2025.
Molecular Partners Ag (MOLN) Goodwill & Intangibles (2020 - 2026) Analysis & Trends
Molecular Partners Ag (MOLN) has reported Goodwill & Intangibles for 7 consecutive years, with $1.28 the latest figure, recorded in Q1 2026.
- Quarterly Goodwill & Intangibles fell 95.22% year-over-year to $1.28 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.28 (down 95.22% YoY) and the FY2025 annual result came in at $2.5, down 100.0% from the prior year.
- Goodwill & Intangibles fell to $1.28 in Q1 2026 per MOLN's latest filing, from $2.5 in the prior quarter.
- Over the last five years, Goodwill & Intangibles for MOLN reached as high as $2.6 million in Q4 2023 and fell as low as $1.28 in Q1 2026.
- A 5-year average of $329040.9 and a median of $301.15 in 2023 frame the typical range for Goodwill & Intangibles.
- Annual changes were most pronounced in 2023 — Goodwill & Intangibles increased 17.51% — and 2025, when it sank 100.0%.
- Year by year, Goodwill & Intangibles stood at $2.2 million in 2022, then gained by 17.51% to $2.6 million in 2023, then sank by 97.84% to $55934.6 in 2024, then plunged by 100.0% to $2.5 in 2025, then tumbled by 48.97% to $1.28 in 2026.
- According to Business Quant data, Goodwill & Intangibles over the past three periods registered $1.28, $2.5, and $6.25 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Molecular Partners Ag | 147.97 Mn | 147.97 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.28 |
| Dec 31, 2025 | 2.50 |
| Sep 30, 2025 | 6.25 |
| Jun 30, 2025 | 12.08 |
| Mar 31, 2025 | 26.69 |
| Dec 31, 2024 | 55,934.57 |
| Sep 30, 2024 | 94.64 |
| Jun 30, 2024 | 134,906.81 |
| Mar 31, 2024 | 189.04 |
| Dec 31, 2023 | 2.59 Mn |
| Sep 30, 2023 | 301.15 |
| Jun 30, 2023 | 308,072.63 |
| Mar 31, 2023 | 310.29 |
| Dec 31, 2022 | 2.20 Mn |
| Sep 30, 2022 | 297.18 |
| Jun 30, 2022 | 302,143.26 |
| Mar 31, 2022 | 308.60 |
| Dec 31, 2021 | 2.06 Mn |
| Sep 30, 2021 | 288.62 |
| Dec 31, 2020 | 1.69 Mn |